As of 2024-09-20, the Intrinsic Value of Gilead Sciences Inc (GILD) is
76.87 USD. This Gilead valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 83.94 USD, the upside of Gilead Sciences Inc is
-8.40%.
The range of the Intrinsic Value is 53.17 - 130.26 USD
76.87 USD
Intrinsic Value
Gilead Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
53.17 - 130.26 |
76.87 |
-8.4% |
| DCF (Growth 10y) |
59.98 - 134.29 |
83.06 |
-1.0% |
| DCF (EBITDA 5y) |
92.94 - 159.89 |
113.19 |
34.8% |
| DCF (EBITDA 10y) |
90.14 - 158.96 |
112.06 |
33.5% |
| Fair Value |
21.12 - 21.12 |
21.12 |
-74.83% |
| P/E |
18.84 - 104.36 |
57.93 |
-31.0% |
| EV/EBITDA |
90.19 - 304.36 |
167.71 |
99.8% |
| EPV |
64.39 - 94.84 |
79.62 |
-5.2% |
| DDM - Stable |
6.33 - 17.45 |
11.89 |
-85.8% |
| DDM - Multi |
75.47 - 122.29 |
90.64 |
8.0% |
Gilead Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
104,504.46 |
| Beta |
0.26 |
| Outstanding shares (mil) |
1,244.99 |
| Enterprise Value (mil) |
125,082.46 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.85% |
| Cost of Debt |
4.28% |
| WACC |
7.78% |